Inhibrx Biosciences, Inc. short interest in 2024
In 2024, Inhibrx Biosciences, Inc.'s disclosed short interest ran from 5.20% of shares outstanding on 15 Aug 2024 to 8.60% on 31 Dec 2024, a change of +3.40 percentage points. The year's high was 8.60% on 31 Dec 2024 and its low 4.68% on 13 Sep 2024, averaging 6.43% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.36 days on 31 Oct 2024. Full history: Inhibrx Biosciences, Inc..
Cite this page
2024 in figures
- Start of year
- 5.20% (15 Aug 2024)
- End of year
- 8.60% (31 Dec 2024)
- Change
- +3.40 pp
- High
- 8.60% (31 Dec 2024)
- Low
- 4.68% (13 Sep 2024)
- Average
- 6.43%
- Highest days to cover
- 23.36 (31 Oct 2024)
- SEC filings marked
- 4
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Aug 2024 | 5.20% | 8.23 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 4.84% | 7.62 | |
| 13 Sep 2024 | 4.68% | 4.94 | |
| 30 Sep 2024 | 5.13% | 6.38 | |
| 15 Oct 2024 | 6.19% | 9.61 | |
| 31 Oct 2024 | 6.75% | 23.36 | |
| 15 Nov 2024 | 7.10% | 13.25 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 7.53% | 14.02 | |
| 13 Dec 2024 | 8.32% | 16.34 | |
| 31 Dec 2024 | 8.60% | 16.10 |
See also: Inhibrx Biosciences, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.